ImmunityBio (IBRX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

ImmunityBio (IBRX) Company Statistics | The Fly

ImmunityBio

· IBRX

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

9.358 B

+6.91%

General

Market Cap: $9.36B
Enterprise Value: $10.62B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 94.63%
Operating Margin: -151.88%
Net Profit Margin: -598.56%
FCF Margin: -220.53%
ROA: -157.89%
ROE: 134.99%
ROIC: -45.01%
Current Ratio: 5.72
Debt-to-Equity: -0.78
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 59.63
P/FCF: —
P/B: —
EV/EBITDA: -11.96

Growth

Rev 1Y: 668.31%
Rev 1Y Fwd Est: 99.12%
Rev 3Y (CAGR): 678.62%
Rev 5Y (CAGR): 184.76%
Rev 10Y (CAGR): 85.41%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $165.79M
Gross Margin: 94.63%
Operating Expenses: $408.68M
Operating Income: -$251.8M
Net Profit: -$992.36M

Balance Sheet

Cash and Equivalents: $75.67M
Working Capital: $362.25M
Total Assets: $628.5M
Net Debt: $737.39M
Total Liabilities: $1.67B
Total Equity: -$1.05B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$356.5M
Cash Flow from Investing: -$308.56M
Cash Flow from Financing: $720.71M
Free Cash Flow: -$365.63M
Capital Expenditures: $9.13M